Trial Profile
A two part study to a) investigate the reproducilibility of the vaginal photoplethysmography (VPP) technique in healthy pre-menopausal volunteers and subjects suffering from Female Sexual Arousal Disorder (FSAD) and b) a randomised double blind, placebo conrolled 4-way crossover study to investigate the effect of single oral doses (10, 50 and 400 mg)of UK-447,841 on vaginal blood flow in pre-menopausal subjects suffering from FSAD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2011
Price :
$35
*
At a glance
- Drugs UK 447841 (Primary)
- Indications Female sexual dysfunction
- Focus Biomarker; Pharmacodynamics
- Sponsors Pfizer
- 15 Aug 2011 New trial record